Skip to main content
Top
Published in: Pediatric Rheumatology 1/2023

Open Access 01-12-2023 | Juvenile Dermatomyositis | Short Report

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity

Authors: Lauren M. Pachman, Gabrielle Morgan, Marisa S. Klein-Gitelman, Najah Ahsan, Amer Khojah

Published in: Pediatric Rheumatology | Issue 1/2023

Login to get access

Abstract

Background

We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly diagnosed, untreated JDM.

Findings

We enrolled 140 untreated JDM and 46 age, race and sex matched healthy controls, ages 2–17. We selected items from the Juvenile Myositis Registry for analysis. Variables include average ERL density of 8 fingers, average capillary pattern, hemorrhages, and clinical and laboratory correlates. Laboratory data includes Myositis Specific Antibodies (MSA), disease activity scores (DAS), Childhood Myositis Assessment Scale (CMAS), and standard clinical serologic data. The reduced mean ERL density is 5.1 ± 1.5/mm for untreated JDM vs 7.9 ± 0.9/mm for healthy controls, p < 0.0001, and is associated with DAS-skin, r = -0.27 p = 0.014, which did not change within the age range tested. Untreated JDM with MSA Tif-1-γ had the lowest ERL density, (p = 0.037); their ERL patterns were primarily “open” and the presence of hemorrhages in the nailfold matrix was associated with dysphagia (p = 0.004).

Conclusions

Decreased JDM ERL density is associated with increased clinical symptoms; nailfold hemorrhages are associated with dysphagia. Duration of untreated disease symptoms and MSA, modify NFC shape. We speculate nailfold characteristics are useful indicators of disease activity in children with JDM before start of therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49(3):300–5. https://doi.org/10.1002/art.11122. PMID: 12794783.CrossRefPubMed Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49(3):300–5. https://​doi.​org/​10.​1002/​art.​11122. PMID: 12794783.CrossRefPubMed
4.
go back to reference Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644–9 PMID: 15290747.PubMed Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644–9 PMID: 15290747.PubMed
5.
9.
go back to reference Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63 Suppl 11(0 11):S118–57. https://doi.org/10.1002/acr.20532. PMID: 22588740; PMCID: PMC3748930.CrossRefPubMed Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63 Suppl 11(0 11):S118–57. https://​doi.​org/​10.​1002/​acr.​20532. PMID: 22588740; PMCID: PMC3748930.CrossRefPubMed
11.
go back to reference Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum. 2005;53(2):166–72. https://doi.org/10.1002/art.21068. PMID: 15818654.CrossRefPubMed Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum. 2005;53(2):166–72. https://​doi.​org/​10.​1002/​art.​21068. PMID: 15818654.CrossRefPubMed
15.
go back to reference Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol. 1994;21(4):739–43 PMID: 8035403.PubMed Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol. 1994;21(4):739–43 PMID: 8035403.PubMed
16.
go back to reference Wienke J, Pachman LM, Morgan GA, Yeo JG, Amoruso MC, Hans V, et al. Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis. Arthritis Rheumatol. 2020;72(7):1214–26. https://doi.org/10.1002/art.41236. Epub 2020 May 29. PMID: 32103637; PMCID: PMC7329617.CrossRefPubMedPubMedCentral Wienke J, Pachman LM, Morgan GA, Yeo JG, Amoruso MC, Hans V, et al. Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis. Arthritis Rheumatol. 2020;72(7):1214–26. https://​doi.​org/​10.​1002/​art.​41236. Epub 2020 May 29. PMID: 32103637; PMCID: PMC7329617.CrossRefPubMedPubMedCentral
17.
go back to reference Kassani PH, Ehwerhemuepha L, Kassab R, Gibbs E, Morgan G, Pachman LM. Artificial intelligence for nailfold capillaroscopy analyses – a proof of concept application in juvenile dermatomyositis. 2023. (in press). Kassani PH, Ehwerhemuepha L, Kassab R, Gibbs E, Morgan G, Pachman LM. Artificial intelligence for nailfold capillaroscopy analyses – a proof of concept application in juvenile dermatomyositis. 2023. (in press).
18.
go back to reference Wang A, Khojah A, Morgan G, Pachman LM. Nailfold capillary dropout precedes the presentation of pneumatosis intestinalis and micro-perforation in juvenile dermatomyositis. Clin Immunol Commun. 2023;3:74–6.CrossRef Wang A, Khojah A, Morgan G, Pachman LM. Nailfold capillary dropout precedes the presentation of pneumatosis intestinalis and micro-perforation in juvenile dermatomyositis. Clin Immunol Commun. 2023;3:74–6.CrossRef
Metadata
Title
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
Authors
Lauren M. Pachman
Gabrielle Morgan
Marisa S. Klein-Gitelman
Najah Ahsan
Amer Khojah
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2023
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-023-00903-x

Other articles of this Issue 1/2023

Pediatric Rheumatology 1/2023 Go to the issue